Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial - Pasquali, S; Palmerini, E; Quagliuolo, V (Cancer, 2022)
et al.